Stocks · Healthcare · Biotechnology
Minerva Neurosciences, Inc. NERV
$3.28 +1.55% Close, Oct 2, 2026 · NASDAQ · Market cap $152.8M
Expensive vs sectorHigh risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-28.87, down 2050.7% year over year.
- The diluted share count rose 945.1% in a year.
- The stock is 59% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- EPS growth (TTM, YoY)Bottom 1%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 35%
- Accruals (lower is better)Bottom 1%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 1%
- Free-cash-flow yieldBottom 1%
- EBITDA / enterprise valueBottom 1%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 15%
- 6-month returnBottom 10%
- 1-year return vs S&P 500Top 25%
- Distance from 52-week highBottom 7%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 41%
- Upside to consensus price targetTop 19%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 19%
- Maximum drawdown, 3 yearsBottom 17%
- Beta vs S&P 500 (lower is better)Bottom 39%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| EPS growth (YoY) | -3656.1% | -2050.7% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| EPS growth (TTM, YoY) | -2050.7% | -3656.1% | ↑ | Bottom 1% |
| Return on invested capital | -38.6% | — | Bottom 35% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 19334.5%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -56.21%
- Shareholder yield
- -56.21%
- Share count change, 1 year
- +945.1%
- Share count change, 3-year CAGR
- +143.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -1.0%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $10.00
- Target vs current price
- +204.9%
- Analysts with a rating
- 7
- Share rating Buy or Strong Buy
- 71%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 7, 2026 | +27.6% | -3.8% | -11.7% | +5.6% | — |
| May 5, 2026 | -2100.0% | -1.3% | -11.1% | -25.0% | -36.5% |
| Mar 11, 2026 | -481.8% | -8.1% | -1.1% | -31.7% | -39.8% |
| Nov 5, 2025 | -2.9% | +4.1% | +8.2% | -9.3% | +27.5% |
| Aug 14, 2025 | +54.7% | -0.6% | +27.1% | +17.7% | +101.1% |
| May 13, 2025 | +53.3% | +0.0% | -11.0% | +10.4% | +10.4% |
| Feb 25, 2025 | +46.7% | +0.0% | -14.5% | +3.4% | -22.9% |
| Nov 5, 2024 | +394.1% | +1.7% | +0.0% | -5.2% | -2.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 7, 2026 | -$0.14 | -$0.19 | +27.6% | — |
| May 5, 2026 | -$2.86 | -$0.13 | -2100.0% | — |
| Mar 11, 2026 | -$0.64 | -$0.11 | -481.8% | — |
| Nov 5, 2025 | -$0.36 | -$0.35 | -2.9% | — |
| Aug 14, 2025 | -$0.43 | -$0.95 | +54.7% | — |
| May 13, 2025 | -$0.50 | -$1.07 | +53.3% | — |
| Feb 25, 2025 | -$0.56 | -$1.05 | +46.7% | $42,218 |
| Nov 5, 2024 | $2.97 | -$1.01 | +394.1% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| Free-cash-flow yield | -12289.23% | — | — | Bottom 1% |
| Earnings yield | -880.18% | — | — | Bottom 1% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.0%
- 200-day average slope (20 days)
- -0.4%
- Distance from 50-day average
- -21.1%
- Distance from 200-day average
- -35.1%
- RSI (14)
- 32.9
- Relative volume
- 0.35×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 78.3%
- Volatility vs own 5-year history
- 43th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.29
- Correlation with S&P 500
- 0.21
- Current drawdown from 1-year high
- -59.4%
- Maximum drawdown, 3 years
- -89.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 27, 2020 | Apr 9, 2025 | -95.8% | 1095 days | Not yet recovered |
| Oct 7, 2020 | Nov 2, 2020 | -12.9% | 18 days | 8 days (Nov 12, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $152.8M
- EPS, diluted (TTM)
- -$28.87
- Revenue (TTM)
- $0
- 52-week range
- $2.08 – $12.46
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 |
| Operating income | -$45.4M | -$25.2M | -$23.1M | -$21.8M | -$15.1M |
| Net income | -$49.9M | -$32.1M | -$30.0M | $1.4M | -$293.4M |
| EPS (diluted) | -$9.35 | -$6.01 | -$4.61 | $0.19 | -$34.67 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | $22.5M | -$4.3M | -$3.8M | -$3.3M | -$2.7M | -$283.7M | -$125.4M | $17.5M |
| EPS (diluted) | $2.97 | -$0.56 | -$0.50 | -$0.43 | -$0.36 | -$25.51 | -$2.86 | -$0.14 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$24.6M | -$24.6M | -$14.8M | -$19.6M | -$13.51B |
| Capital expenditure | $0 | -$16,326 | $0 | $0 | $0 |
| Free cash flow | -$24.6M | -$24.7M | -$14.8M | -$19.6M | -$13.51B |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | $0 | $20.0M | $0 | $74.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $75.3M
- Total assets
- $95.1M
- Total liabilities
- $296.6M
- Total debt
- $0
- Net debt
- -$24.7M
- Shareholders’ equity
- -$201.6M
As of Jun 30, 2026 (filed Aug 7, 2026).
Short interest
- Shares sold short
- 2,421,652
- Days to cover
- 20.13
- Change vs previous report
- +14.6%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 21, 2022
- 1-for-8